Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients

被引:4
作者
Gimotty, Phyllis A. [1 ]
Guerry, DuPont [2 ]
Flaherty, Keith [2 ]
机构
[1] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Abramson Canc Ctr,Melanoma Program, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Med, Abramson Canc Ctr,Melanoma Program,Div Hematol On, Philadelphia, PA 19104 USA
关键词
D O I
10.1200/JCO.2007.14.3156
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:517 / 518
页数:2
相关论文
共 7 条
[1]
Amaravadi Ravi K, 2007, Clin Adv Hematol Oncol, V5, P386
[2]
Current developments of immunotherapy in the clinic [J].
Antonia, S ;
Mulé, JJ ;
Weber, JS .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (02) :130-136
[3]
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[4]
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme [J].
Ballman, Karla V. ;
Buckner, Jan C. ;
Brown, Paul D. ;
Giannini, Caterina ;
Flynn, Patrick J. ;
LaPlant, Betsy R. ;
Jaeckle, Kurt A. .
NEURO-ONCOLOGY, 2007, 9 (01) :29-38
[5]
Flexible two-stage design with sample size reassessment for survival trials [J].
Desseaux, K. ;
Porcher, R. .
STATISTICS IN MEDICINE, 2007, 26 (27) :5002-5013
[6]
Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials [J].
Korn, Edward L. ;
Liu, Ping-Yu ;
Lee, Sandra J. ;
Chapman, Judith-Anne W. ;
Niedzwiecki, Donna ;
Suman, Vera J. ;
Moon, James ;
Sondak, Vernon K. ;
Atkins, Michael B. ;
Eisenhauer, Elizabeth A. ;
Parulekar, Wendy ;
Markovic, Svetomir N. ;
Saxman, Scott ;
Kirkwood, John M. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :527-534
[7]
Surrogate end points for median overall survival in metastatic colorectal cancer: Literature-based analysis from 39 Randomized controlled trials of first-line chemotherapy [J].
Tang, Patricia A. ;
Bentzen, Soren M. ;
Chen, Eric X. ;
Siu, Lillian L. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) :4562-4568